Pharmacology and Toxicology

Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro

This article has 6 authors:
1. Geoffrey S. Dow
2. Angela Luttick
3. Jen Fenner
4. David Wesche
5. Karen Rowland Yeo
6. Craig Rayner
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Jul 12, 2020Latest activity Mar 1, 2021
In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2

This article has 5 authors:
1. Hoai Thi Thu Tran
2. Philipp Peterburs
3. Jan Seibel
4. D. Abramov-Sommariva
5. Evelyn Lamy
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 1, 2021Latest activity Mar 15, 2021
Pharmacokinetics of Orally Administered GS-441524 in Dogs

This article has 13 authors:
1. Victoria C. Yan
2. Cong-Dat Pham
3. Matthew J. Yan
4. Alexander J. Yan
5. Sunada Khadka
6. Kenisha Arthur
7. Jeffrey J. Ackroyd
8. Dimitra K. Georgiou
9. Laura E. Roon
10. Lane R. Bushman
11. Peter L. Anderson
12. Chun Li
13. Florian L. Muller
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 31, 2021Latest activity Mar 1, 2021
Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein’s Receptor Binding Domain and Recombinant Human ACE2

This article has 3 authors:
1. Omonike A. Olaleye
2. Manvir Kaur
3. Collins C. Onyenaka
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Sep 14, 2020Latest activity Mar 1, 2021
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro

This article has 12 authors:
1. Dean Gilham
2. Audrey L. Smith
3. Li Fu
4. Dalia Y. Moore
5. Abenaya Muralidharan
6. St. Patrick M. Reid
7. Stephanie C. Stotz
8. Jan O. Johansson
9. Michael Sweeney
10. Norman C. W. Wong
11. Ewelina Kulikowski
12. Dalia El-Gamal
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 18, 2021Latest activity Mar 15, 2021
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction

This article has 16 authors:
1. Michele Biagioli
2. Silvia Marchianò
3. Rosalinda Roselli
4. Cristina Di Giorgio
5. Rachele Bellini
6. Martina Bordoni
7. Anna Gidari
8. Samuele Sabbatini
9. Daniela Francisci
10. Bianca Fiorillo
11. Bruno Catalanotti
12. Eleonora Distrutti
13. Adriana Carino
14. Angela Zampella
15. Gabriele Costantino
16. Stefano Fiorucci
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 1, 2021Latest activity Mar 1, 2021
Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro

This article has 8 authors:
1. Francesca Curreli
2. Sofia M. B. Victor
3. Shahad Ahmed
4. Aleksandra Drelich
5. Xiaohe Tong
6. Chien-Te K. Tseng
7. Christopher D. Hillyer
8. Asim K. Debnath
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 22, 2020Latest activity Mar 1, 2021
Blockade of SARS-CoV-2 infection in vitro by highly potent PI3K-α/mTOR/BRD4 inhibitor

This article has 9 authors:
1. Arpan Acharya
2. Kabita Pandey
3. Michellie Thurman
4. Kishore B. Challagundala
5. Kendra R. Vann
6. Tatiana G. Kutateladze
7. Guillermo A Morales
8. Donald L. Durden
9. Siddappa N. Byrareddy
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 5, 2021Latest activity Mar 15, 2021
Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro

This article has 8 authors:
1. Senem Merve Fred
2. Suvi Kuivanen
3. Hasan Ugurlu
4. Plinio Cabrera Casarotto
5. Lev Levanov
6. Kalle Saksela
7. Olli Vapalahti
8. Eero Castrén
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 19, 2022Latest activity Mar 25, 2021
Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model

This article has 12 authors:
1. Jianling Yang
2. Zhengyang Guo
3. Xu Liu
4. Qi Liu
5. Meng Wu
6. Xueting Yao
7. Yang Liu
8. Cheng Cui
9. Haiyan Li
10. Chunli Song
11. Dongyang Liu
12. Lixiang Xue
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Nov 20, 2020Latest activity Mar 1, 2021

Previous Page 18 of 21 Next

Pharmacology and Toxicology

Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro

In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2

Pharmacokinetics of Orally Administered GS-441524 in Dogs

Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein’s Receptor Binding Domain and Recombinant Human ACE2

Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro

Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction

Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro

Blockade of SARS-CoV-2 infection in vitro by highly potent PI3K-α/mTOR/BRD4 inhibitor

Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro

Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model